SALIX PHARMACEUTICALS LTD·4

Jun 17, 5:15 PM ET

SALIX PHARMACEUTICALS LTD 4

4 · SALIX PHARMACEUTICALS LTD · Filed Jun 17, 2013

Insider Transaction Report

Form 4
Period: 2013-06-13
Transactions
  • Tax Payment

    Common Stock

    2013-06-13$65.04/sh1,040$67,64287,524 total
Holdings
  • Common Stock

    (indirect: By LP)
    260
  • Common Stock

    (indirect: By Spouse)
    6,500
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: By Trust)
    1,080
  • Option to Buy Common Stock

    Exercise: $18.87Exp: 2014-06-17Common Stock (22,500 underlying)
    22,500
Footnotes (3)
  • [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
  • [F2]The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
  • [F3]Options are 100% vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION